GlaxoSmithKline shifts OTC media

Share this article:

GlaxoSmithKline said it will shift media buying and planning for its North American OTC brands to WPP's MediaCom by the end of February. MediaCom already handles buying and planning tasks for the firm's prescription drug business.

Media duties on the OTC business—which includes brands like Panadol, Aquafresh, Lucozade and Nicorette—had been split among Havas' MPG, MediaCom, Publicis' Optimedia and Campbell Mithun.

It's not the first time in recent years that GSK has upended its marketing vendors. Last year the company moved all of its professional advertising from WPP agencies to IPG ones.  

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.